Allergan Plc Executives

Allergan Plc employs about 17.4 K people. The company is managed by 35 executives with a total tenure of roughly 293 years, averaging almost 8.0 years of service per executive, having 497.14 employees per reported executive. Analysis of Allergan Plc's management performance can provide insight into the firm performance.
Brenton Saunders  Chairman
Chairman of the Board, President, Chief Executive Officer
Paul Bisaro  Chairman
Executive Chairman
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Allergan Plc Management Team Effectiveness

The company has Return on Asset of (0.0564) % which means that on every $100 spent on assets, it lost $0.0564. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0913) %, meaning that it generated no profit with money invested by stockholders. Allergan Plc's management efficiency ratios could be used to measure how well Allergan Plc manages its routine affairs as well as how well it operates its assets and liabilities.

Allergan Plc Workforce Comparison

Allergan Plc is number one stock in number of employees category among related companies. The total workforce of Drug Manufacturers—General industry is presently estimated at about 39,523. Allergan Plc totals roughly 17,400 in number of employees claiming about 44% of equities under Drug Manufacturers—General industry.

Allergan Plc Notable Stakeholders

An Allergan Plc stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Allergan Plc often face trade-offs trying to please all of them. Allergan Plc's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Allergan Plc's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Brenton SaundersChairman of the Board, President, Chief Executive OfficerProfile
Paul BisaroExecutive ChairmanProfile
Matthew WalshChief Financial Officer, Executive Vice PresidentProfile
Robert StewartExecutive VP and President of Generic and Global OperationsProfile
William MeuryExecutive Vice President, Chief Commercial OfficerProfile
Wayne SwantonExecutive Vice President - Global OperationsProfile
Karen LingChief Human Resource Officer, Executive Vice PresidentProfile
Philippe SchaisonExecutive Vice President and President Allergan MedicalProfile
A BaileyExecutive Vice President, Chief Legal Officer and Corporate SecretaryProfile
CDavid NicholsonExecutive Vice President, Chief R&D OfficerProfile
Jonathon KellermanExecutive Vice President Chief Compliance OfficerProfile
Paul NavarreExecutive Vice President and President International BrandsProfile
Maria HiladoCFO and Executive VPProfile
Ronald TaylorIndependent DirectorProfile
Adriane BrownIndependent DirectorProfile
Robert HuginIndependent DirectorProfile
Christopher BodineIndependent DirectorProfile
Michael GallagherLead Independent DirectorProfile
Thomas FreymanIndependent DirectorProfile
Catherine KlemaLead Independent DirectorProfile
Christopher CoughlinLead Independent DirectorProfile
Nesli BasgozIndependent DirectorProfile
Joseph BoccuziIndependent DirectorProfile
Patrick OSullivanIndependent DirectorProfile
Fred WeissIndependent DirectorProfile
Carol DavidsonIndependent DirectorProfile
Michael GreenbergIndependent DirectorProfile
Ron TaylorIndependent DirectorProfile
James BloemIndependent DirectorProfile
Peter McDonnellIndependent DirectorProfile
Robert BaileyChief Legal Officer and Corporate SecretaryProfile
NicholsonChief R&D OfficerProfile
James DAreccaChief Accounting OfficerProfile
Alex KellyChief Communications OfficerProfile
Karina CalzadillaIR Contact OfficerProfile

Allergan Plc Workforce Analysis

Traditionally, organizations such as Allergan Plc use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Allergan Plc within its industry.

Allergan Plc Manpower Efficiency

Return on Allergan Plc Manpower

Revenue Per Employee909.2K
Revenue Per Executive452M
Net Loss Per Employee531.6K
Net Loss Per Executive264.3M
Working Capital Per Employee16.5K
Working Capital Per Executive8.2M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Allergan Plc information on this page should be used as a complementary analysis to other Allergan Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Consideration for investing in Allergan Stock

If you are still planning to invest in Allergan Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allergan Plc's history and understand the potential risks before investing.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing